Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left ventricular dysfunction should restrict physical exertion, competitive sports, and isometric exercises until they have undergone appropriate surgical interventions, such as valve replacement.
Pharmacologic Therapy
Pharmacologic therapy is the cornerstone of managing AR. Vasodilators, particularly angiotensin-converting enzyme (ACE) inhibitors and calcium channel blockers, are pivotal in reducing cardiac afterload. These medications decrease left ventricular volume overload, enhance cardiac output, and alleviate symptoms. Beta-blockers, though used cautiously due to their potential to exacerbate symptoms in some patients, can slow the heart rate, reduce myocardial oxygen demand, and improve diastolic filling time, which collectively helps manage AR. Additionally, restricting sodium intake is advised to prevent volume overload, further aiding in symptom control and reducing the burden on the heart. This dietary modification is essential in preventing the exacerbation of AR symptoms and left ventricular dilation.
Surgical Intervention
Surgical intervention becomes imperative when pharmacologic therapy fails to control symptoms or when significant left ventricular dilation is evident. Surgery is recommended for any patient with an ejection fraction of ≤ 50% or for symptomatic patients, regardless of the severity of left ventricular dysfunction. Surgical options primarily include aortic valve replacement or valvuloplasty. Performing surgery before the onset of left ventricular failure is crucial to ensure optimal outcomes and long-term cardiac function preservation.
Patient Education and Monitoring
Teaching patients about medication adherence, lifestyle modifications, and vigilant monitoring for symptom progression is paramount. Patients should adhere to prescribed medications, follow dietary sodium restrictions, and avoid activities that may exacerbate symptoms. They should also be informed about the potential signs of worsening AR, such as increasing dyspnea, fatigue, or palpitations, and the necessity of regular follow-ups with their healthcare provider.
Management of aortic regurgitation, or AR, includes the following.
Symptomatic patients or those with significant left ventricular dysfunction should avoid physical exertion, competitive sports, and isometric exercise until they undergo valve replacement.
Pharmacologic therapy is crucial in managing AR.
Pharmacologic therapy includes vasodilators, such as angiotensin-converting enzyme inhibitors and calcium channel blockers, which reduce afterload, decrease left ventricular overload, and improve cardiac output.
Beta-blockers are used cautiously to slow the heart rate, reduce myocardial oxygen demand, and improve diastolic filling time.
Additionally, patients are educated on medication adherence, lifestyle changes, sodium restriction, and monitoring symptoms.
Lastly, surgery, including valve replacement or valvuloplasty, is recommended for severe AR with symptoms. It is also recommended for asymptomatic patients with an ejection fraction less than or equal to 50 percentandpatients with significant left ventricular dilation and an end-systolic diameter greater than 50 millimeters.
繁體中文
